Athira Pharma, Inc. (ATHA) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Athira Pharma, Inc. (ATHA) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

ATHA Income Statement

Athira Pharma, Inc. (ATHA) annual income statement — 8-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	0	67.4M	243K	200K	243K	0	0	242K	242K	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	-67.4M	-243K	-200K	-243K	0	0	-242K	-242K	0	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	100%	100%	-	-	17.36%	-0.41%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	19.45M	18.14M	11.16M	6.63M	7.09M	9.29M	15.57M	29.62M	27.79M	27.45M	29.01M	35.04M	31.64M	29.77M	32.93M	24.13M	23.57M	23.39M	18.78M	17.83M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	6.58M	6.88M	3.77M	4.05M	3.63M	5.23M	6.2M	7.57M	5.87M	6.45M	6.96M	7.84M	10.03M	8.48M	7.69M	7.17M	8.77M	8.93M	6.16M	7.12M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	12.7M	11.26M	6.96M	2.58M	3.66M	4.3M	9.37M	17.92M	21.91M	20.99M	23.68M	27.2M	21.61M	21.29M	15.24M	16.96M	14.8M	14.46M	12.62M	10.71M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	175K	0	443K	0	-200K	-243K	0	1000K	0	0	-1000K	0	0	0	1000K	0	0	0	0	0
Operating Income	-19.45M	-17.21M	-78.56M	-6.87M	-7.29M	-9.54M	-15.57M	-29.62M	-28.03M	-27.69M	-29.01M	-35.04M	-31.64M	-29.77M	-32.93M	-24.13M	-23.57M	-23.39M	-18.78M	-17.83M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-166.81%	-80.52%	-404.72%	76.79%	73.99%	65.56%	46.35%	15.47%	11.42%	7%	11.88%	-45.2%	-34.24%	-27.29%	-75.35%	-35.38%	-41.67%	-116.93%	-106.83%	-140.99%
EBITDA	-19.45M	-17.21M	-78.32M	-6.77M	-7.09M	-9.29M	-15.32M	-29.38M	-27.79M	-27.45M	-28.77M	-34.8M	-31.4M	-29.53M	-32.69M	-23.9M	-23.35M	-23.23M	-18.65M	-17.7M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-174.33%	-85.24%	-411.15%	76.97%	74.48%	66.14%	46.74%	15.58%	11.5%	7.07%	11.99%	-45.59%	-34.47%	-27.12%	-75.25%	-35.02%	-41.34%	-117.76%	-142.2%	-139.34%
D&A (Non-Cash Add-back)	0	0	241K	108K	200K	243K	243K	243K	242K	242K	245K	244K	244K	236K	239K	231K	221K	154K	126K	123K
EBIT	0	0	22.72M	-6.61M	-6.97M	-9.14M	-15.57M	-25.49M	-28.03M	-27.69M	-30.64M	-35.04M	-31.64M	-29.61M	-21.7M	-21.17M	-24.83M	-21.15M	-16.34M	-15.75M
Net Interest Income	0	0	-981K	263K	325K	393K	563K	880K	1.17M	1.35M	-221K	2.07M	0	0	-173K	987K	493K	173K	103K	73K
Interest Income	0	0	-981K	263K	325K	393K	563K	880K	1.17M	1.35M	1.73M	2.07M	0	0	0	987K	493K	175K	105K	74K
Interest Expense	0	0	0	0	0	0	0	0	0	0	1.95M	0	0	0	173K	0	0	2K	2K	1K
Other Income/Expense	446K	-15.73M	-4.32M	263K	325K	393K	563K	880K	1.17M	1.35M	1.73M	2.07M	2.04M	1.95M	2.79M	3.94M	-766K	2.41M	2.44M	2.15M
Pretax Income	-19.01M	-32.95M	-82.89M	-6.61M	-6.97M	-9.14M	-15M	-28.74M	-26.86M	-26.34M	-27.29M	-32.97M	-29.6M	-27.82M	-30.14M	-20.19M	-24.34M	-20.98M	-16.34M	-15.67M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-19.01M	-32.95M	-82.89M	-6.61M	-6.97M	-9.14M	-15M	-28.74M	-26.86M	-26.34M	-27.29M	-32.97M	-29.6M	-27.82M	-30.14M	-20.19M	-24.34M	-20.98M	-16.34M	-15.67M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-172.85%	-260.36%	-452.48%	77%	74.06%	65.28%	45.01%	12.83%	9.25%	5.33%	9.46%	-63.31%	-21.62%	-32.6%	-84.44%	-28.81%	-74.14%	-136.63%	-112.14%	-85.36%
Net Income (Continuing)	-19.01M	-32.95M	-82.89M	-6.61M	-6.97M	-9.14M	-15M	-28.74M	-26.86M	-26.34M	-27.29M	-32.97M	-29.6M	-27.82M	-30.14M	-20.19M	-24.34M	-20.98M	-16.34M	-15.67M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.80	-1.73	-18.94	-1.68	-1.78	-2.30	-3.90	-7.50	-7.00	-6.90	-7.20	-8.70	-7.80	-6.80	-6.80	-4.30	-6.50	-4.90	-4.40	-4.20
EPS Growth %	55.06%	24.78%	-385.64%	77.6%	74.57%	66.67%	45.83%	13.79%	10.26%	-1.47%	-5.88%	-102.33%	-20%	-38.78%	-54.55%	-2.38%	-71.05%	-96%	-83.33%	-55.56%
EPS (Basic)	-0.80	-1.73	-18.94	-1.68	-1.78	-2.30	-3.90	-7.50	-7.00	-6.90	-7.20	-8.70	-7.80	-6.80	-6.80	-4.30	-6.50	-4.90	-4.40	-4.20
Diluted Shares Outstanding	23.73M	19.03M	4.28M	3.94M	3.91M	3.9M	3.85M	3.85M	3.84M	3.83M	3.81M	3.81M	3.8M	3.79M	3.78M	3.78M	3.77M	3.76M	3.74M	3.73M
Basic Shares Outstanding	23.73M	19.03M	4.28M	3.94M	3.91M	3.9M	3.85M	3.85M	3.84M	3.83M	3.81M	3.81M	3.8M	3.79M	3.78M	3.78M	3.77M	3.76M	3.74M	3.73M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-